Phase III trials demonstrate promise for new oral treatments

被引：0
|
作者：
不详
机构：
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2010年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [11] Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
    Mandel, Jacob J.
    Yust-Katz, Shlomit
    Patel, Akash J.
    Cachia, David
    Liu, Diane
    Park, Minjeong
    Yuan, Ying
    Kent, Thomas A.
    de Groot, John F.
    [J]. NEURO-ONCOLOGY, 2018, 20 (01) : 113 - 122
  • [12] An analysis of net clinical benefit of new oral anticoagulants versus warfarin in atrial fibrillation phase III trials
    Renda, G.
    Di Nicola, M.
    De Caterina, R.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1107 - 1107
  • [13] Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer
    Gan, Hui K.
    You, Benoit
    Pond, Gregory R.
    Chen, Eric X.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) : 590 - 598
  • [14] New trends in assessment in anticancer treatments by phase II clinical trials
    Medioni, JR
    de Rycke, Y
    Asselain, B
    [J]. BULLETIN DU CANCER, 2000, 87 (7-8) : 551 - 556
  • [15] Phase 0 clinical trials: facts and promise
    Rodon, J.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 67 - 67
  • [16] New Chemical Entities Entering Phase III Trials in 2011
    Notte, Gregory T.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 477 - 498
  • [17] New Chemical Entities Entering Phase III Trials in 2012
    Notte, Gregory T.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 451 - 469
  • [18] New Chemical Entities Entering Phase III Trials in 2013
    Notte, Gregory T.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 417 - 436
  • [19] Entasis antibiotic shows phase III promise
    Mullard, Asher
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (12) : 888 - 888
  • [20] Entasis antibiotic shows phase III promise
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2021, 20 : 888 - 888
12345